Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10701933rdf:typepubmed:Citationlld:pubmed
pubmed-article:10701933lifeskim:mentionsumls-concept:C0008281lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C0012522lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C0004259lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C0014479lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C0022023lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C0002611lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C0055737lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C1705938lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C1527178lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C0140175lld:lifeskim
pubmed-article:10701933lifeskim:mentionsumls-concept:C0233929lld:lifeskim
pubmed-article:10701933pubmed:issue4lld:pubmed
pubmed-article:10701933pubmed:dateCreated2000-3-8lld:pubmed
pubmed-article:10701933pubmed:abstractTextIon-associate complexes of ephedrine HCl (I), cinchonine HCl (II), chlorpheniramine maleate (III), atropine sulphate (IV) and diphenhydramine HCl (V) with ammonium reineckate were precipitated and their solubilities were studied as a function of pH, ionic strength and temperature. Saturated solutions of each ion-associate under the optimum precipitation conditions were prepared and the Cr ion content in the supernatant was determined. The solubility products were thus elucidated at different temperatures. A new accurate and precise method using direct current plasma-atomic emission spectrometry for the determination of the investigated drugs in pure solutions and in pharmaceutical preparations is described. The drugs can determined by the present method in the ranges 1.6-52,2.64-85.8,3.12-101.4,5.52-180.4 and 2.72-75.85 microg/ml solutions of I, II, III, IV and V, respectively.lld:pubmed
pubmed-article:10701933pubmed:languageenglld:pubmed
pubmed-article:10701933pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10701933pubmed:citationSubsetIMlld:pubmed
pubmed-article:10701933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10701933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10701933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10701933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10701933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10701933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10701933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10701933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10701933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10701933pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10701933pubmed:statusMEDLINElld:pubmed
pubmed-article:10701933pubmed:monthDeclld:pubmed
pubmed-article:10701933pubmed:issn0731-7085lld:pubmed
pubmed-article:10701933pubmed:authorpubmed-author:KhalilSSlld:pubmed
pubmed-article:10701933pubmed:issnTypePrintlld:pubmed
pubmed-article:10701933pubmed:volume21lld:pubmed
pubmed-article:10701933pubmed:ownerNLMlld:pubmed
pubmed-article:10701933pubmed:authorsCompleteYlld:pubmed
pubmed-article:10701933pubmed:pagination697-702lld:pubmed
pubmed-article:10701933pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:meshHeadingpubmed-meshheading:10701933...lld:pubmed
pubmed-article:10701933pubmed:year1999lld:pubmed
pubmed-article:10701933pubmed:articleTitleAtomic emission spectrometric determination of ephedrine, cinchonine, chlorpheniramine, atropine and diphenhydramine based on formation of ion associates with ammonium reineckate.lld:pubmed
pubmed-article:10701933pubmed:affiliationChemistry Department, Faculty of Science, Cairo University, Fayoum, Egypt.lld:pubmed
pubmed-article:10701933pubmed:publicationTypeJournal Articlelld:pubmed